New pertussis vaccine

A. Correia De Sousa (Porto, Portugal)

Source: Virtual Congress 2021 – Vaccination and infections
Session: Vaccination and infections
Session type: Joint session
Number: 70

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Correia De Sousa (Porto, Portugal). New pertussis vaccine. Virtual Congress 2021 – Vaccination and infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New Influenza vaccines
Source: Virtual Congress 2021 – Vaccination and infections
Year: 2021


Pertussis: waning immunity after vaccination in adults and recent increase of pertussis in infants
Source: Eur Respir J 2001; 18: Suppl. 33, 154s
Year: 2001

Use of the pneumococcal 23-valent polysaccharide vaccine in recruits in Russia
Source: Eur Respir J 2004; 24: Suppl. 48, 363s
Year: 2004

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
Source: Eur Respir J 2015; 46: 1407-1416
Year: 2015



Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


Pneumococcal and influenza vaccination
Source: Eur Respir Monogr 2014; 63: 266-284
Year: 2014


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004



Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010

Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population
Source: Eur Respir J 2016; 48: 1492-1496
Year: 2016


Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001



Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Pneumococcal vaccination
Source: Eur Respir J 2005; 26: 982-983
Year: 2005


Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005

Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018